News Biosynex

Stocks

ALBIO

FR0011005933

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:55:00 2026-10-16 EDT			5-day change	1st Jan Change
0.8400 ^EUR	-0.47%		-1.18%	+40.94%

10-12	Biosynex exits safeguard proceedings with court approval
09-04	Biosynex: creditors to vote on financial safeguard plan

All News

Mentions Relevance

10-12	Biosynex exits safeguard proceedings with court approval
09-04	Biosynex: creditors to vote on financial safeguard plan
08-06	Biosynex hit by cyberattack, operational activity remains intact
06-11	Triple update for Biosynex
06-10	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
05-25	Biosynex announces the divestment of its molecular biology business
05-24	An undisclosed buyer signed a binding offer to acquire Entire internal molecular biology business from Biosynex SA for ?4 million.	CI
05-07	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-06	Biosynex SA Auditor Raises 'Going Concern' Doubt	CI
04-21	Biosynex postpones publication of annual accounts
03-24	Observation period extended for Biosynex
02-06	A Biosynex Subsidiary to Receive $1.8 Million Grant
01-22	Biosynex Announces FDA Review Request for a Product
01-16	Biosynex: To Watch Today
01-15	Biosynex Targets Gradual Business Restart in 2026
12-31	Biosynex: To Watch Today
12-30	Biosynex: Brigitte Geny Resigns from Her Position as Independent Director
25-10-30	Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-29	Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-01-21	Biosynex SA announced that it expects to receive ?7.987161 million in funding	CI
25-01-14	Biosynex: 9% sales growth by 2024
24-11-03	Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-10-23	BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY	EQ
24-07-19	Biosynex: return to growth, share price rises
24-05-28	Biosynex: obtains CE markings under the new IVDR regulations